Previous 10 | Next 10 |
Citi analyst Joel Beatty has downgraded shares of Alnylam (ALNY) from buy/high risk to neutral/high risk amid upside threats.Beatty, however, increased his price target $5 to $175.He cities competitor threats to Alnylam's hereditary ATTR (amyloidosis) business from Eidos Therapeutics' (EIDX) ...
BridgeBio Pharma (BBIO) announced that it has completed its acquisition of all of the outstanding shares of Eidos Therapeutics (EIDX).BridgeBio agreed to acquire all of the outstanding common stock of Eidos it did not already own, representing ~36.3% of outstanding shares, in Octobe...
PALO ALTO, Calif., Jan. 26, 2021 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (“BridgeBio”) (Nasdaq: BBIO) today announced that it has completed its acquisition of all of the outstanding shares of Eidos Therapeutics, Inc. (“Eidos”) (formerly Nasdaq: EIDX) common st...
Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m. on Seeking Alpha, iTunes, Stitcher and Spotify. Economic reports in the week ahead A blockbuster week of earnings is on tap with heavyweights like Apple (NASDAQ:AAPL), Microsoft (NASDAQ:MSFT) and Caterpi...
PALO ALTO, Calif. and SAN FRANCISCO, Jan. 19, 2021 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (“BridgeBio”) (Nasdaq: BBIO) and Eidos Therapeutics, Inc. (“Eidos”) (Nasdaq: EIDX) today announced that the stockholders of each of BridgeBio and Eidos voted to approve ...
Merger activity decreased last week with six new deals announced. Acacia Communications and Cisco Systems announced an amendment to their merger agreement. Google completes the acquisition of Fitbit. For further details see: Merger Arbitrage Mondays - Fitbit Closes And A...
PALO ALTO, Calif. and SAN FRANCISCO, Jan. 13, 2021 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (“BridgeBio”) (Nasdaq: BBIO) and Eidos Therapeutics, Inc. (“Eidos”) (Nasdaq: EIDX) announced today that the acquisition of shares of common stock of Eidos not held by Br...
Merger activity increased significantly last week with eight new deals announced. The acquisition of Alaska Communications Systems Group by ATN International. The acquisition of FLIR Systems by Teledyne Technologies Incorporated. For further details see: Merger...
NEW YORK, NY / ACCESSWIRE / January 8, 2021 / Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: CounterPath Corporation (NASDAQ:CPAH) concerning potential violations of the federal securities laws and/or breaches of fiduciary...
Merger activity decreased last week with one new deal announced. The acquisition of Red Lion Hotels (RLH) by Sonesta International Hotels. Perella Weinberg Partners and FinTech Acquisition Corp. IV enter into a definitive business combination agreement. For further details s...
News, Short Squeeze, Breakout and More Instantly...
Eidos Therapeutics Inc. Company Name:
EIDX Stock Symbol:
NASDAQ Market:
Eidos Therapeutics Inc. Website:
PALO ALTO, Calif., Jan. 26, 2021 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (“BridgeBio”) (Nasdaq: BBIO) today announced that it has completed its acquisition of all of the outstanding shares of Eidos Therapeutics, Inc. (“Eidos”) (formerly Nasdaq: EIDX) common st...
PALO ALTO, Calif. and SAN FRANCISCO, Jan. 19, 2021 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (“BridgeBio”) (Nasdaq: BBIO) and Eidos Therapeutics, Inc. (“Eidos”) (Nasdaq: EIDX) today announced that the stockholders of each of BridgeBio and Eidos voted to approve ...
PALO ALTO, Calif. and SAN FRANCISCO, Jan. 13, 2021 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (“BridgeBio”) (Nasdaq: BBIO) and Eidos Therapeutics, Inc. (“Eidos”) (Nasdaq: EIDX) announced today that the acquisition of shares of common stock of Eidos not held by Br...